Issue 1: Top 20 Most Innovative Healthcare Technology Companies In 2019

ISSUE 1: TOP 20 MOST INNOVATIVE HEALTHCARE TECHNOLOGY COMPANIES IN 2019

ISSUE 1: Digital Magazine
Healthcare-COVERPAGE-1-250x310_c

Anne Wojcicki, Co-Founder & CEO

23andMe

23andMe is a human genome research company enabling users to study their ancestry, genealogy, and inherited traits.Our mission is to help people access, understand and benefit from the human genome.

Peter Hickey, CEO

Peter Hickey, CEO

Adaptiiv Medical Technologies

A 67-year-old female was treated at the Nova Scotia Health Authority for mycosis fungoides of the forehead, eyelid, and nose with mycosis fungoides involving the upper face. As a part of her treatment plan, the application of bolus for Modulated Electron Radiation Therapy (MERT) was necessary to deliver the prescribed dose to the skin surface to treat her disease with two separate electron fields.

Matthew Stoudt, CEO

AppliedVR

AppliedVR is the leader in therapeutic virtual reality, transforming healthcare through the power of pixels. Since its founding in 2015, appliedVR has delivered scientifically designed and validated digital health solutions to over 20,000 patients in more than 250 hospitals and in 8 countries globally. The company’s leading digital wellness platform has been used to impact chronic pain as well as acute pain and anxiety experiences before, after, and during surgery, child labor, oncology infusions, emergency room procedures, and rehabilitation sessions.

Dr. Abraham Heifets CEO

Atomwise

Atomwise patented the first deep learning technology for structure-based small molecule drug discovery. This AI technology harnesses millions of data points and thousands of protein structures to solve problems that a human chemist would take many lifetimes to solve. We’ve partnered with some of the world’s largest pharmaceutical and agrochemical companies, and with more than 50 leading academic institutions and hospitals, to tackle the challenges of discovering and developing better drugs and chemicals. Recently, Atomwise raised $45 million from leading venture capital firms to support the development and application of its AI technology.

Joanna Shields, CEO

BenevolentAI

BenevolentAI is the global leader in the development and application of artificial intelligence (“AI”) for scientific innovation. We aim to accelerate the journey from inventive ideas to medicines for patients by developing AI to generate new treatments for some of the world’s 8,000 untreated diseases.

Josef Scheiber, MD & Founder

BioVariance

Medical errors are as fatal as terminal diseases. Often numerous patients die due to the recurring medical errors in the healthcare systems. The modern healthcare sector is continuously challenged with this festering issue as they strive to deliver safe and higher quality care.

Jacob Lee, CEO

Jacob Lee, CEO

CAIDE Systems

Despite the upheaval that AI has created in the healthcare space, the lack of well-annotated data has been the biggest challenge in the development of disease detection AI engines. It slows the process and is very expensive. Moreover, annotation and labeling demand a heavy workload from medical doctors in the development stage of medical AI engines. Applying his extensive experience in objective recognition for medical image-based diagnosis using AI deep learning, Jacob Lee found the perfect solution to reduce the burden from this data annotation and labeling process.

Tanveer Patel Co-Founder & CEO

Concert Care

Digitization has crawled into every phase of healthcare. As consumers of healthcare are gaining more medical knowledge, the demand for better service and outcomes is increasing like never before; and the only means to meet this need is through technology. “The best way to deliver healthcare to all at high quality is to be preventative and reach the consumers early before they need it,” notes Tanveer Patel, Co-Founder and CEO of ConcertCare.

Brendan Frey, Founder & CEO

Deep Genomics

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.

Nat Turner, Co-Founder & CEO

Flatiron Health

Flatiron Health is a healthcare technology company, develops software that connects community oncologists, academics, hospitals, life science researchers, and regulators on a shared technology platform.It offers Flatiron Platform, a web-based business and clinical intelligence data platform that integrates and structures disparate information systems to produce a view of the patient population, provides analytics for business intelligence, resource utilization, marketing, treatment patterns, network management, and research and clinical trials, and allows cancer care providers and life sciences companies to track metrics related to cancer care, monitor adherence to national guidelines across their clinicians, match patients to clinical trials in real-time, and ask custom questions of their data.

Mike Klein, CEO

Genomenon

A software solution that allows rapid, automated, and accurate analysis of next-generation sequencing data to speed up discovery work and diagnosis.

Dan Burton, CEO

Health Catalyst

Health Catalyst is dedicated to enabling health care organizations to fundamentally improve care by building the most comprehensive and fully integrated suite of healthcare data warehousing and process improvement solutions available.Health Catalyst was formed by a group of healthcare veterans with vast data warehousing and quality improvement experience. Our founders and executives collaborated for nearly a decade to revolutionize clinical process models using analytics. During development, they faced numerous hurdles in the quest to develop a data warehouse that could handle the complexities unique to healthcare data.

Jun Wang, Founder & CEO

iCarbonX

iCarbonX is a technology company that is changing how people monitor and understand their health status and optimize their lives. We are building the platform and tools for digitizing, analyzing, and understanding life, and delivering intelligent products and applications—designed for every aspect and stage of life—to help everyone make smarter choices, every day.

Joseph M. DeVivo, CEO

InTouch Health

InTouch Health provides the most reliable, dedicated cloud-based network and virtual care solutions that ensure connectivity for health systems, providers, and patients at all times. Today, InTouch Health supports more than 2,500 care locations around the world – including many of the top 20 health systems – as they deploy telehealth programs across their enterprises. InTouch Health has surpassed 2.2 million network sessions, which includes 1,000,000 telehealth virtual care sessions over the InTouch Telehealth Network.

Christopher J. Ianelli, MD, CEO

iSpecimen Inc.

During his service at the Brigham and Women’s Hospital in Boston, Dr. Christopher Ianelli noticed a software solution that orchestrated the distribution of leftover specimens to researchers developed within the clinical laboratory of the hospital. Acknowledging that these “clinical remnant” specimens held tremendous value for medical research, he quickly realized the power of this solution to reduce waste and accelerate research by connecting bench researchers to a steady supply of remnant clinical samples.

Justin Barad, MD Co-Founder & CEO

Osso VR

Osso VR is an award winning VR surgical and medical device training platform. The company is made up of practicing clinicians, professional VR developers and medtech industry veterans. We specialize in hyper-realistic, haptic-enhanced, hands-on interactivity and design.

Erik de Heus, CEO

SkinVision

SkinVision is an awareness and tracking solution that supports individuals with the early recognition of melanoma, squamous cell carcinoma, basal cell carcinoma and precancerous actinic keratosis. SkinVision is the first certified skin cancer application globally based on extensive clinical trials in partnership with the university clinic of Ludwig Maximilian University (LMU) in Munich in 2013, published in the JEADV in 2014. The company has built up a customer portfolio of 1,200,000 users globally and a database of 3,5 million pictures of suspicious skin conditions.

Dirk Wagener, GM

Stone Three Healthcare

Cardiovascular disease or CVD is a global problem. Though typically viewed as a “rich-world disease”, it has now migrated to many developing countries. The rising prevalence of CVD, today, calls for cost-effective and intelligent patient-centric healthcare technology that empowers care teams and has a real impact on patients.

Gabriela Fuentes, COO

Transmural Biotech S.L

The value of AI has been accelerating the healthcare space at an increasing rate. In fact, AI-powered medical diagnostics is today driving the critical changes across the care continuum. However, AI technologies are not believed to replace doctors despite its transformative power. “We view AI only as a new medical device that allows doctors to ‘better see’ each case,” says Gabriela Fuentes, COO, Transmural Biotech or TMB. “For instance, doctors with different degrees of training reach different conclusions on a clinical diagnosis. Instead, if they have access to data-driven AI image processing technology to support their decision, objective results can be attained regardless of their training.” Upholding the same principle, TMB develops innovative clinical solutions and services using disruptive technologies based on AI.

Nersi Nazari, CEO

Vitalconnect

VitalConnect provides physicians, nurses and patients with an extraordinary advancement in healthcare. Never before has so much continuous monitoring of vital signs been possible in a single, small—yet powerful—device. By consolidating eight critical vital signs into one wireless biosensor,VitalPatch enables a new view into healthcare, but more importantly it connects all interested parties in a patient’s recovery with each other.

22

Technology Depends on Faster Adoption of Innovation

When Electronic Medical Records (EMRs) were introduced in the early 1970s the vision was clear: digitizing patient records would make healthcare more efficient, and better for the patient and provider. Fast forward to today—we’ve come a long way towards the goal of a better system, but we aren’t quite there. We’ve identified the industry’s pain points, and laid the groundwork for solutions. Widespread adoption of the three healthcare tech ideas below will be crucial to building a healthcare system that is better for patients and the clinicians alike. Interoperability and SMART on FHIR: In 2018, the Centers for Medicare and Medicaid (CMS) renamed “Meaningful Use” to “Promoting Interoperability”, which is a good indicator that we are inching closer to greater efficiency in healthcare.

ceo

Shining a light between the rock and the hard place:

Apps, and their use for the promotion of health and wellbeing, are the subject of increasing interest and enquiry; particularly in light of the NHS’ Long Term Plan, and ever-increasing pressures on scarce NHS resources. But finding and downloading effective, engaging, and most importantly, safe health-apps, is a significant challenge. While many have suggested that health-apps could be a ‘silver-bullet’, aimed at quashing the woes that stem from decreasing funding and increasing demand for incumbent NHS services, it is important to tread with caution. Unlike pharmaceuticals, over the counter remedies, talking therapies, physiotherapy or surgery, health-apps can not only be sought, but readily obtained in absence of gatekeeping and safeguarding.

Stephane Bourles, CIO at Brain Balance

AI to help kids struggling with ADHD, Asperger Syndrome (ASD) & PDD-NOS

In a properly functioning brain, both hemispheres communicate equally and at lightning speed, millions of times per minute. In a poorly functioning brain, the left and right sides of the brain only impart partial information, causing frequent miscommunication. This is called Functional Disconnection and is the root of many types of learning, behavioral and social problems found in children. The Brain Balance program puts the left and right brains back in sync using sensory motor exercises, academic skill building, and nutrition guidelines.  The assessment consists of sensory, motor, and academic testing of more than 900 functions. The outcome of this assessment is a highly customized report providing parents with a complete understanding of their child’s behavioral, social, and academic skill levels.

All About Breast Tightening and Liposuction

All About Breast Tightening and Liposuction

Women with overly large breasts can face a number of difficulties on a physiological and psychological level, such as being unable to find clothes that fit properly, permanent indentations left behind by their bras from carrying the immense weight of their bosoms, or suffering from chronic pain in regions like their back, neck, and shoulders that can affect their day-to-day living. In these cases, breast tightening and liposuction procedures like Breast-Tite—a form of radiofrequency-assisted (RFA) liposuction designed to perform what is known as a scar-less breast lift—can improve your daily life. If you haven’t heard of this innovative procedure before, you may want to take notes, as it provides a fantastic alternative to traditional breast lift and breast reduction surgeries! Learn more about breast tightening and liposuction down below!

a

Defining Healthcare Trends to Watch in 2018

The healthcare industry tackles the opioid crisis: Opioid overdoses are now the leading cause of death for US adults younger than 50. This is a phenomenon too big to solve by only one player – there is a role for everyone across the healthcare landscape, from prescribers, to payers, to the pharmaceutical industry, in order to reverse this trend.

Social determinants come to the forefront: The US spends more on healthcare per capita per year than any other nation, but lags in outcomes. To improve health while saving money, the industry needs to expand the borders of healthcare. This means thinking beyond the four walls of the hospital and looking holistically at the full profile of a patient, beyond their specific health issue.

health-costs

New Model for Estimating Healthcare Costs

When we ask employees about their financial security, they tell us their number one stressor is not saving enough for retirement. After that, they worry about the economy and after that, their personal health. But when we ask them what defines a good lifestyle once they stop working and what is the most important factor affecting financial security in retirement, they place health at the top of both lists. Meanwhile, as another survey has found, retirees are feeling less confident that they will be able to afford medical care and long-term care. It’s hard to know how much savings will be needed to cover healthcare expenses in retirement. The conventional approach of estimating a lifetime total cost for healthcare expenses in retirement and targeting savings to cover that amount clearly does not work for everyone, as most people have difficulty saving for retirement at all.

The Effectiveness of Stem Cell Therapy for Motor Neuron Disease Treatment

The Effectiveness of Stem Cell Therapy for Motor Neuron Disease Treatment

Motor neuron diseases are neurodegenerative. They are caused when the motor neurons do not function properly in the brain. These are the nerve cells responsible for controlling the muscles that facilitate the body movement. They carry the signals from the brain to the different muscles of the body. When they fail, the patients find extreme problems in simple body movements like speaking, walking, turning, and standing. These medical conditions lead to MND which is a progressive neurological degenerative disease affecting the motor neurons in the body. Many types of research are conducted to find a proper treatment for this incurable disease. The stem cell therapy is seen as a potential cure for motor neuron disease treatment in India.  The Role of Stem Cells in Treatment of MND: No medication has proved effective to control the progression of this serious disease in the long-term.